Eosinophilic Asthma

• CLINICAL_TRIALS research · 2026-04-24
  Clinical Trial Update: Mepolizumab and Physical Activity in Severe Asthma

  This document reports an update on a clinical trial evaluating mepolizumab with physical activity in severe asthma; the study is currently a…

• CLINICAL_TRIALS research · 2026-04-23
  Clinical Trial Update: A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma [Phase 2]

  This entry describes a Phase 2 clinical trial evaluating KT-621 taken orally in adults with moderate-to-severe eosinophilic asthma; recruitm…

• CLINICAL_TRIALS research · 2026-04-09
  Clinical Trial Update: A Real-life Observational Study in Severe Eosinophilic Asthma Adult Participant Treated With Benralizumab in Italy

  A real-world observational study in adults with severe eosinophilic asthma in Italy is evaluating outcomes for patients treated with benrali…

• CLINICAL_TRIALS research · 2026-03-19
  Clinical Trial Update: Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment [Phase 3]

  Phase 3 trial evaluating benralizumab 30 mg SC as add-on therapy in uncontrolled eosinophilic asthma patients on medium-dose ICS-LABA, compa…

• CLINICAL_TRIALS research · 2026-01-15
  Clinical Trial Update: Beyond EOsinophils: proteoMICS to Identify Potential Biomarker of Organ Damage and Response to MEPOLIZUMAB in EGPA [Phase 4]

  A Phase 4 clinical trial update describes using proteoMICS to identify biomarkers of organ damage and response to mepolizumab in eosinophili…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2025-12-18
  Clinical Trial Update: A Study to Evaluate the Long-term Safety, Pharmacodynamics and Efficacy of SHR-1703 in Eosinophilic Asthma Patients [Phase 2]

  A Phase 2 clinical trial to evaluate the long-term safety, pharmacodynamics, and efficacy of SHR-1703 in patients with eosinophilic asthma, …

• CLINICAL_TRIALS research · 2025-12-11
  Clinical Trial Update: Treatment With Mepolizumab on Patients With Severe Refractory Eosinophilic Asthma

  This clinical trial update notes that a study evaluating mepolizumab in patients with severe refractory eosinophilic asthma has been complet…

• CLINICAL_TRIALS research · 2025-11-26
  Clinical Trial Update: A Multi-dose Study on the Safety and Efficacy of Self-administered Intranasal AD17002 Treatment for Eosinophilic Asthma [Phase 2]

  A Phase 2 multi-dose study of a self-administered intranasal treatment (AD17002) for eosinophilic asthma is listed as not yet recruiting.

• CLINICAL_TRIALS research · 2025-08-11
  Clinical Trial Update: Evaluating the Effect of Benralizumab in Severe, Poorly-controlled Eosinophilic Asthma Using Inhaled Hyperpolarized 129-Xenon MRI [NA]

  This entry describes a clinical trial evaluating benralizumab for severe eosinophilic asthma using inhaled hyperpolarized Xenon-129 MRI, wit…

• CLINICAL_TRIALS research · 2025-04-04
  Clinical Trial Update: Eosinophil Subpopulations in Eosinophilic-associated Diseases

  A University of Florence trial update notes a study on eosinophil subpopulations in eosinophilic diseases. The study includes eosinophilic a…

• CLINICAL_TRIALS research · 2025-02-19
  Clinical Trial Update: The Influence of Mepolizumab on Structural and Inflammatory Cells in Severe Eosinophilic Asthma

  ClinicalTrials.gov update describes a study examining the effect of mepolizumab on structural and inflammatory cells in adults with severe e…

• CLINICAL_TRIALS research · 2024-04-26
  Clinical Trial Update: Predictive Signature of Benralizumab Response [Phase 4]

  A Phase 4 clinical trial is evaluating a predictive biomarker signature for benralizumab response in eosinophilic asthma with severe feature…